Cytokeratin 17 Polyclonal Antibody

KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in KRT17 lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.

The Cytokeratin 17 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of Cytokeratin 17 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human Cytokeratin 17 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards Cytokeratin 17 protein, making it an ideal tool for various research applications, including immunohistochemistry, western blotting, and ELISA.

The Cytokeratin 17 Polyclonal Antibody is supplied as a liquid formulation in phosphate-buffered saline (PBS) with 0.02% sodium azide as a preservative. It is available in various sizes to meet the needs of different research projects. This antibody is a valuable tool for researchers studying the role of Cytokeratin 17 in various physiological and pathological processes, including cancer, wound healing, and tissue regeneration.